申请人:MERLA Beatrix
公开号:US20090005427A1
公开(公告)日:2009-01-01
Substituted oxadiazole compounds corresponding to formula I:
in which X denotes CH, CH
2
, CH═CH, CH
2
CH
2
, CH
2
CH═CH or CH
2
CH
2
CH
2
; R
1
denotes aryl or heteroaryl, in each case unsubstituted or mono- or polysubstituted; or a C
1-3
alkyl group-linked aryl or heteroaryl group, in each case unsubstituted or mono- or polysubstituted; R
2
denotes aryl or heteroaryl, in each case unsubstituted or mono- or polysubstituted; a C
1-3
alkyl chain-attached aryl group, in each case unsubstituted or mono- or polysubstituted; and R
3
and R
4
independently denote H; C
1-6
alkyl, in each case saturated or unsaturated, branched or unbranched, wherein R
3
and R
4
do not simultaneously mean H; or R
3
and R
4
together denote CH
2
CH
2
OCH
2
CH
2
, or (CH
2
)
3-6
. The compounds have an affinity for the μ-opioid receptor and may take the form of the racemate; enantiomers, diastereomers, mixtures of enantiomers or diastereomers, an individual enantiomer or diastereomer, a free base, or a salt with a physiologically acceptable acid.
将与式I对应的氧代二唑化合物替换为:其中X表示CH、CH2、CH═CH、CH2CH2、CH2CH═CH或CH2CH2CH2;R1表示芳基或杂环基,每种情况下未取代或单取代或多取代;或者与芳基或杂环基连接的C1-3烷基基团,每种情况下未取代或单取代或多取代;R2表示芳基或杂环基,每种情况下未取代或单取代或多取代;连接有C1-3烷基链的芳基基团,每种情况下未取代或单取代或多取代;R3和R4独立地表示H;C1-6烷基,每种情况下饱和或不饱和,支链或直链,其中R3和R4不同时表示H;或者R3和R4一起表示CH2CH2OCH2CH2,或(CH2)3-6。这些化合物对μ-阿片受体具有亲和力,可能采取消旋体的形式;对映异构体、二对映异构体、对映异构体或二对映异构体的混合物、单个对映异构体或二对映异构体、游离碱或与生理上可接受的酸形成盐。